Lerdsin General Hospital
1 clinical trials · Sponsor
◉ Watch Lerdsin General Hospital
| Record | Firm | Date |
|---|---|---|
| Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy (NCT00949351) | Lerdsin General Hospital | 2009-09-01 |
Track Lerdsin General Hospital automatically
Every clearance here is in the API, with alerts when new ones post.